PortfoliosLab logo
SIRI vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SIRI and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

SIRI vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sirius XM Holdings Inc. (SIRI) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

SIRI:

-0.32

ABBV:

0.83

Sortino Ratio

SIRI:

-0.11

ABBV:

1.21

Omega Ratio

SIRI:

0.99

ABBV:

1.19

Calmar Ratio

SIRI:

-0.19

ABBV:

1.17

Martin Ratio

SIRI:

-0.53

ABBV:

2.66

Ulcer Index

SIRI:

34.31%

ABBV:

9.07%

Daily Std Dev

SIRI:

55.69%

ABBV:

28.28%

Max Drawdown

SIRI:

-99.92%

ABBV:

-45.09%

Current Drawdown

SIRI:

-96.05%

ABBV:

-13.31%

Fundamentals

Market Cap

SIRI:

$7.57B

ABBV:

$327.88B

EPS

SIRI:

-$5.05

ABBV:

$2.34

PEG Ratio

SIRI:

0.66

ABBV:

0.40

PS Ratio

SIRI:

0.88

ABBV:

5.72

PB Ratio

SIRI:

0.67

ABBV:

230.90

Total Revenue (TTM)

SIRI:

$8.61B

ABBV:

$57.37B

Gross Profit (TTM)

SIRI:

$4.13B

ABBV:

$44.44B

EBITDA (TTM)

SIRI:

-$864.00M

ABBV:

$16.36B

Returns By Period

In the year-to-date period, SIRI achieves a -2.70% return, which is significantly lower than ABBV's 6.70% return. Over the past 10 years, SIRI has underperformed ABBV with an annualized return of -3.97%, while ABBV has yielded a comparatively higher 15.54% annualized return.


SIRI

YTD

-2.70%

1M

2.49%

6M

-17.68%

1Y

-17.48%

3Y*

-28.29%

5Y*

-15.52%

10Y*

-3.97%

ABBV

YTD

6.70%

1M

-4.61%

6M

3.65%

1Y

23.40%

3Y*

12.26%

5Y*

19.77%

10Y*

15.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Sirius XM Holdings Inc.

AbbVie Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

SIRI vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SIRI
The Risk-Adjusted Performance Rank of SIRI is 3535
Overall Rank
The Sharpe Ratio Rank of SIRI is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of SIRI is 3232
Sortino Ratio Rank
The Omega Ratio Rank of SIRI is 3232
Omega Ratio Rank
The Calmar Ratio Rank of SIRI is 3838
Calmar Ratio Rank
The Martin Ratio Rank of SIRI is 3939
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 7777
Overall Rank
The Sharpe Ratio Rank of ABBV is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 7070
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 7474
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8585
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SIRI vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sirius XM Holdings Inc. (SIRI) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SIRI Sharpe Ratio is -0.32, which is lower than the ABBV Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of SIRI and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

SIRI vs. ABBV - Dividend Comparison

SIRI's dividend yield for the trailing twelve months is around 4.96%, more than ABBV's 3.43% yield.


TTM20242023202220212020201920182017201620152014
SIRI
Sirius XM Holdings Inc.
4.96%4.68%1.81%5.82%1.04%0.86%0.69%0.79%0.76%0.22%0.00%0.00%
ABBV
AbbVie Inc.
3.43%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

SIRI vs. ABBV - Drawdown Comparison

The maximum SIRI drawdown since its inception was -99.92%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for SIRI and ABBV.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

SIRI vs. ABBV - Volatility Comparison

Sirius XM Holdings Inc. (SIRI) has a higher volatility of 13.51% compared to AbbVie Inc. (ABBV) at 9.85%. This indicates that SIRI's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

SIRI vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Sirius XM Holdings Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
2.07B
13.34B
(SIRI) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

SIRI vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Sirius XM Holdings Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%20212022202320242025
46.6%
83.9%
(SIRI) Gross Margin
(ABBV) Gross Margin
SIRI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sirius XM Holdings Inc. reported a gross profit of 964.00M and revenue of 2.07B. Therefore, the gross margin over that period was 46.6%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.

SIRI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sirius XM Holdings Inc. reported an operating income of 387.00M and revenue of 2.07B, resulting in an operating margin of 18.7%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.

SIRI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sirius XM Holdings Inc. reported a net income of 204.00M and revenue of 2.07B, resulting in a net margin of 9.9%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.